Skip to main content
. 2020 Nov 4;10:19036. doi: 10.1038/s41598-020-76074-6

Table 2.

Number of patients with each co-morbidity by quartile of HHL (arm span − body height).

Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-value
Prevalent vertebral fracture, No. (%) 27 (11.5) 36 (15.3) 70 (29.7) 132 (56.2)  < 0.001
Spinal osteoarthritis, No. (%) 105 (44.7) 139 (58.9) 165 (69.9) 205 (87.2)  < 0.001
Diabetes mellitus, No. (%) 33 (14.0) 45 (19.1) 30 (12.7) 26 (11.1) 0.08
Dyslipidemia, No. (%) 125 (53.2) 128 (54.2) 108 (45.8) 100 (42.6) 0.03
Hypertension, No. (%) 99 (42.1) 115 (48.7) 144 (61.0) 172 (73.2)  < 0.001
Vascular events, No. (%) 16 (6.8) 30 (12.7) 39 (16.5) 53 (22.6)  < 0.001
GERD, No. (%) 9 (3.8) 13 (5.5) 22 (9.3) 36 (15.3)  < 0.001

Quartile 1 ranged from − 12.5 to − 0.2 cm (n = 235).

Quartile 2 ranged from − 0.1 to 3.7 cm (n = 236).

Quartile 3 ranged from 3.8 to 7.6 cm (n = 236).

Quartile 4 ranged from 7.7 to 24.0 cm (n = 235).

HHL, historical height loss; GERD, gastroesophageal reflux disease.